Rapport Therapeutics (RAPP) CEO Ceesay Abraham Sells Shares

What Happened Ceesay Abraham, CEO of Rapport Therapeutics (RAPP), sold a total of 51,499 shares in open-market transactions on August 10–11, 2026, for aggregate gross proceeds of approximately $2,433,176. The individual reported trades were:

• 8/10/2026: 14,171 shares at a weighted avg. $45.97 — $651,492 (prices ranged $45.37–$46.36).
• 8/10/2026: 8,370 shares at a weighted avg. $46.75 — $391,280 (prices ranged $46.38–$47.01).
• 8/11/2026: 3,664 shares at a weighted avg. $46.90 — $171,837 (prices ranged $46.32–$47.29).
• 8/11/2026: 19,500 shares at a weighted avg. $48.04 — $936,846 (prices ranged $47.45–$48.43).
• 8/11/2026: 5,794 shares at a weighted avg. $48.62 — $281,721 (prices ranged $48.45–$48.87).

These were sales (S), which are typically routine dispositions rather than bullish signals.

Key Details

• Transaction dates: August 10 and 11, 2026. Filing date: August 12, 2026.
• Total shares sold: 51,499; total reported proceeds: ≈ $2,433,176.
• Each reported price is a weighted average; actual sales occurred at multiple prices within the ranges noted above (the filer will provide a full breakdown on request).
• Trades were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2026 (pre-scheduled trades).
• Shares owned after the transactions: not specified in the supplied summary — see the Form 4 for post-transaction beneficial ownership.
• Transaction code: S = Sale. Filing appears timely (filed two days after the first reported trades).

Context

• Sales under a 10b5-1 plan are pre-arranged and common for insiders to manage planned dispositions; they do not necessarily reflect the insider’s current view of the company.
• For retail investors, purchases are generally more informative about insider confidence; routine sales like these are frequently for diversification or liquidity.
• For the precise per-trade price breakdown or holdings after the transactions, refer to the full Form 4 filing or request the details the reporting person agreed to provide.